State Street Corp Harrow Health, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Harrow Health, Inc. stock. As of the latest transaction made, State Street Corp holds 715,419 shares of HROW stock, worth $32.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
715,419
Previous 635,372
12.6%
Holding current value
$32.7 Million
Previous $8.41 Million
77.81%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HROW
# of Institutions
129Shares Held
19.8MCall Options Held
700KPut Options Held
564K-
Opaleye Management Inc. Boston, MA3.99MShares$182 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$124 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$98.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$84 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$32.8 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.24B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...